Shiraz E-Medical Journal

Published by: Kowsar

Age of Substance Use Onset in Kermanshah Province: Results from a Large Cross-Sectional Study

Behrooz Hamzeh 1 , Zeinab Moradinazar 1 , Mehdi Moradinazar 1 , Farid Najafi 1 , * and Shahab Rezaeian 1
Authors Information
1 Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
Article information
  • Shiraz E-Medical Journal: 20 (3); e74366
  • Published Online: September 17, 2018
  • Article Type: Research Article
  • Received: May 6, 2018
  • Revised: June 24, 2018
  • Accepted: June 25, 2018
  • DOI: 10.5812/semj.74366

To Cite: Hamzeh B, Moradinazar Z, Moradinazar M, Najafi F, Rezaeian S. Age of Substance Use Onset in Kermanshah Province: Results from a Large Cross-Sectional Study, Shiraz E-Med J. Online ahead of Print ; 20(3):e74366. doi: 10.5812/semj.74366.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Footnote
References
  • 1. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization; 2004. Available from: http://www.who.int/hiv/pub/idu/pubidu/en/.
  • 2. Uosukainen H, Tacke U, Winstock AR. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. Int J Drug Policy. 2015;26(1):78-83. doi: 10.1016/j.drugpo.2014.07.004. [PubMed: 25107829].
  • 3. Donohew L, Sypher HE, Bukoski WJ. Persuasive communication and drug abuse prevention. London and New York: Routledge; 2012. doi: 10.4324/9780203052419.
  • 4. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. [PubMed: 19464218].
  • 5. Black C. It will never happen to me: Growing up with addiction as youngsters, adolescents, adults. Center City, Minnesota, U.S: Hazelden Publishing; 2009.
  • 6. Loeffler AG. The indigenisation of allopathic medicine in Iran. Anthropol Mid East. 2008;3(2). doi: 10.3167/ame.2008.030206.
  • 7. Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iran Med. 2002;5(3):184-90.
  • 8. United Nations Office on Drugs and Crime. World Drug Report 2010. Vienna, Austria: United Nations Publication; 2010. Available from: https://www.unodc.org/unodc/data-and-analysis/WDR-2010.html.
  • 9. Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: Recommendations and rationale. Am J Psychiatry. 2013;170(8):834-51. doi: 10.1176/appi.ajp.2013.12060782. [PubMed: 23903334]. [PubMed Central: PMC3767415].
  • 10. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: The past, present, and future. Lancet. 2010;376(9737):268-84. doi: 10.1016/S0140-6736(10)60743-X. [PubMed: 20650523].
  • 11. Patel S, Rescigno R, Zarbin M, Bhagat N. Endogenous endophthalmitis associated with intravenous drug abuse. Invest Ophthalmol Visual Sci. 2013;54(15):1115.
  • 12. Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J Appl Sci. 2005;5(2):380-2. doi: 10.3923/jas.2005.380.382.
  • 13. Rostami M, Karamouzian M, Khosravi A, Rezaeian S. Gender and geographical inequalities in fatal drug overdose in Iran: A province-level study in 2006 and 2011. Spat Spatiotemporal Epidemiol. 2018;25:19-24. doi: 10.1016/j.sste.2018.01.001. [PubMed: 29751889].
  • 14. Brady JE, Li G. Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010. Am J Epidemiol. 2014;179(6):692-9. doi: 10.1093/aje/kwt327. [PubMed: 24477748]. [PubMed Central: PMC3939850].
  • 15. Campello G, Sloboda Z, Heikkil H, Brotherhood A. International standards on drug use prevention: the future of drug use prevention world-wide. Int J Prev Treat Subs Use Disord. 2014;1(2):6. doi: 10.4038/ijptsud.v1i2.7687.
  • 16. Boles SM, Miotto K. Substance abuse and violence: A review of the literature. Aggress Violent Behav. 2003;8(2):155-74. doi: 10.1016/s1359-1789(01)00057-x.
  • 17. Grant JE, Chamberlain SR. Impulsive action and impulsive choice across substance and behavioral addictions: Cause or consequence? Addict Behav. 2014;39(11):1632-9. doi: 10.1016/j.addbeh.2014.04.022. [PubMed: 24864028].
  • 18. Moghanibashi-Mansourieh A, Deilamizade A. The state of data collection on addiction in Iran. Addiction. 2014;109(5):854. doi: 10.1111/add.12505. [PubMed: 24606041].
  • 19. Hassanzadeh J, Moradi N, Esmailnasab N, Rezaeian S, Bagheri P, Armanmehr V. The correlation between gender inequalities and their health related factors in world countries: A global cross-sectional study. Epidemiol Res Int. 2014;2014:1-8. doi: 10.1155/2014/521569.
  • 20. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26(4):479-88. doi: 10.1016/S0893-133X(01)00367-0. [PubMed: 11927172].
  • 21. Olthuis JV, Darredeau C, Barrett SP. Substance use initiation: The role of simultaneous polysubstance use. Drug Alcohol Rev. 2013;32(1):67-71. doi: 10.1111/j.1465-3362.2012.00470.x. [PubMed: 22612987].
  • 22. Acheampong A, Striley CW, Fakunle DO, Cottler L. Sex, drugs, and violence: An analysis of women in drug court. Drug Alcohol Depend. 2015;156:e2-3. doi: 10.1016/j.drugalcdep.2015.07.925.
  • 23. Hoggatt KJ, Jamison AL, Lehavot K, Cucciare MA, Timko C, Simpson TL. Alcohol and drug misuse, abuse, and dependence in women veterans. Epidemiol Rev. 2015;37:23-37. doi: 10.1093/epirev/mxu010. [PubMed: 25608962].
  • 24. Xie H, McHugo GJ, Fox MB, Drake RE. Special section on relapse prevention: Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatr Serv. 2005;56(10):1282-7. doi: 10.1176/appi.ps.56.10.1282. [PubMed: 16215196].
  • 25. Cuijpers P. Effective ingredients of school-based drug prevention programs. A systematic review. Addict Behav. 2002;27(6):1009-23. [PubMed: 12369469].
  • 26. Kikhavandi S, Menati R, Kassani A, Menati W. [Associated factors with addiction relapse in patients of referring to addiction treatment centers in Ilam: A case-control study]. J Ilam Univ Med Sci. 2015;22(6):165-73. Persian.
  • 27. Giraudon I, Lowitz K, Dargan PI, Wood DM, Dart RC. Prescription opioid abuse in the UK. Br J Clin Pharmacol. 2013;76(5):823-4. doi: 10.1111/bcp.12133. [PubMed: 23594290]. [PubMed Central: PMC3853541].
  • 28. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2012 national survey on drug use and health: Summary of national findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments